Parallax Volatility Advisers L.P. Purchases New Holdings in Bath & Body Works, Inc. $BBWI

Parallax Volatility Advisers L.P. bought a new position in Bath & Body Works, Inc. (NYSE:BBWIFree Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 42,679 shares of the company’s stock, valued at approximately $987,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in shares of Bath & Body Works in the 2nd quarter worth $449,065,000. AQR Capital Management LLC lifted its position in shares of Bath & Body Works by 132.5% during the fourth quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company’s stock valued at $229,834,000 after buying an additional 6,523,960 shares during the last quarter. Norges Bank purchased a new position in Bath & Body Works in the fourth quarter worth $55,504,000. Balyasny Asset Management L.P. acquired a new position in Bath & Body Works during the 4th quarter valued at about $54,785,000. Finally, Bank of America Corp DE acquired a new position in shares of Bath & Body Works in the second quarter valued at about $62,249,000. Institutional investors own 95.14% of the company’s stock.

Analysts Set New Price Targets

BBWI has been the subject of a number of recent research reports. Morgan Stanley reiterated an “equal weight” rating and set a $22.00 price objective on shares of Bath & Body Works in a research note on Monday, July 6th. Piper Sandler began coverage on Bath & Body Works in a research report on Friday, May 15th. They set a “neutral” rating and a $20.00 price target for the company. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. Barclays cut their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research report on Thursday, May 28th. Finally, TD Cowen upped their target price on shares of Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Four investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $22.57.

Read Our Latest Research Report on BBWI

Trending Headlines about Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

  • Positive Sentiment: Bath & Body Works reported second-quarter adjusted EPS of $0.62, well above the $0.24 analyst consensus, while revenue of $1.51 billion slightly exceeded expectations. Bath & Body Works Q2 Earnings and Revenues Surpass Estimates
  • Positive Sentiment: Management raised fiscal 2026 adjusted EPS guidance to $2.60-$2.80, above its previous range of $2.40-$2.65 and ahead of the roughly $2.56 consensus. The company also reiterated revenue expectations of approximately $7.5-$7.6 billion. Bath & Body Works Raises Earnings Outlook on Higher Profit
  • Positive Sentiment: Digital demand and direct-channel sales growth are offsetting weaker physical-store traffic. Management also highlighted ongoing transformation initiatives, including planned cost savings, stronger cash flow and potential balance-sheet improvement that could support future shareholder returns. Bath & Body Works lifts annual profit forecast
  • Neutral Sentiment: The earnings call and bullish commentary frame BBWI as a discounted turnaround opportunity, but investors will likely require sustained sales growth and execution before assigning a higher valuation.
  • Negative Sentiment: Second-quarter net sales declined 2.3% year over year, and third-quarter adjusted EPS guidance of only $0.07-$0.12 is substantially below the approximately $0.27 consensus. The outlook reflects continued near-term pressure from store traffic and seasonality. Bath & Body Works falls despite earnings beat
  • Negative Sentiment: Heavy put-option activity ahead of the report signaled elevated bearish hedging and helps explain the stock’s volatility despite the earnings beat.

Bath & Body Works Stock Up 7.6%

Shares of NYSE:BBWI opened at $18.92 on Thursday. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $32.32. The company has a market cap of $3.81 billion, a price-to-earnings ratio of 5.31, a PEG ratio of 1.73 and a beta of 1.38. The firm’s 50-day simple moving average is $20.36 and its 200-day simple moving average is $20.01.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.38. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.50 billion. During the same quarter in the prior year, the firm posted $0.30 EPS. The company’s revenue was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, research analysts forecast that Bath & Body Works, Inc. will post 2.63 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Friday, August 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, August 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.2%. Bath & Body Works’s dividend payout ratio (DPR) is presently 22.47%.

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Featured Articles

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.